Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
mrt5005 (1 trial)
mrt5201 (1 trial)
Cystic Fibrosis (Phase 2)
Fibrosis (Phase 2)
Ornithine Carbamoyltransferase Deficiency Disease (Phase 2)
Trials (2 total)
Trial APIs (2 total)